OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma
Yoshinobu Shigekawa, Shinya Hayami, Masaki Ueno, et al.
Oncotarget (2018) Vol. 9, Iss. 76, pp. 34320-34335
Open Access | Times Cited: 38

Showing 26-50 of 38 citing articles:

RETRACTED: KDM5B-mediated microRNA-448 up-regulation restrains papillary thyroid cancer cell progression and slows down tumor growth via TGIF1 repression
Ying Pu, Juan Xiang, Jiani Zhang
Life Sciences (2020) Vol. 250, pp. 117519-117519
Closed Access | Times Cited: 13

Evidence for context-dependent functions of KDM5B in prostate development and prostate cancer
Bigang Liu, Rahul Kumar, Hseuh-Ping Chao, et al.
Oncotarget (2020) Vol. 11, Iss. 46, pp. 4243-4252
Open Access | Times Cited: 13

Histone Demethylase Modulation: Epigenetic Strategy to Combat Cancer Progression
Rashmi Srivastava, Rubi Singh, Shaurya Jauhari, et al.
Epigenomes (2023) Vol. 7, Iss. 2, pp. 10-10
Open Access | Times Cited: 4

Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections
Ali Shojaeian, Mohsen Nakhaie, Zahra Sobhi Amjad, et al.
Journal of Cancer Metastasis and Treatment (2024)
Open Access | Times Cited: 1

Histone methyltransferase SUV420H1/KMT5B contributes to poor prognosis in hepatocellular carcinoma
Hirotaka Kato, Shinya Hayami, Masaki Ueno, et al.
Cancer Science (2023) Vol. 115, Iss. 2, pp. 385-400
Open Access | Times Cited: 3

A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma
Torsten Diesinger, Alfred Lautwein, Sebastian Bergler, et al.
Canadian Journal of Gastroenterology and Hepatology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 7

KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity
Shirin Jamshidi, Steven Catchpole, Jie Chen, et al.
International Journal of Oncology (2021) Vol. 59, Iss. 5
Open Access | Times Cited: 7

KDM5B expression in cisplatin resistant neuroblastoma cell lines
Marie Belhajová, Natalia Podhorska, Aleš Vícha, et al.
Oncology Letters (2022) Vol. 24, Iss. 4
Open Access | Times Cited: 4

Prognostic value of elevated KDM5B expression in patients with laryngeal squamous cell carcinoma.
Hongcun Sun, Wenbo Jiang, Jiandao Hu, et al.
PubMed (2019) Vol. 12, Iss. 9, pp. 3500-3506
Closed Access | Times Cited: 4

An updated review on the significance of DNA and protein methyltransferases and de-methylases in human diseases: From molecular mechanism to novel therapeutic approaches
Mohammad Ghanbari, Negin Sadi Khosroshahi, Maryam Alamdar, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 23, pp. 3550-3587
Closed Access | Times Cited: 1

Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease
Xu Li, Yuhong Fan, Xiao‐Jing Zhang, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 5, pp. 703-715
Open Access

Epigenetic modifications and regulations in gastrointestinal diseases
Aditi Bhattacharya
Elsevier eBooks (2023), pp. 497-543
Closed Access

Previous Page - Page 2

Scroll to top